Biolevate
Paris, France
◆ Total Raised
$34.4M
◆ Stage
series-a
◆ Location
Paris, France
◆ Founded
2024
◆ Team size
11-50
◆ Links
◆ About Biolevate
Paris-based life sciences AI company providing an enterprise agentic AI platform for automating scientific and regulatory workflows in drug development.
◆ What sets it apart
It combines scientific evidence, regulatory knowledge, company context, and governed AI agents to automate regulated work with auditability and human oversight.
◆ Sectors
◆ Business
ModelSaaS
CustomerLife sciences organizations, including pharma and biotech teams handling scientific, regulatory, and operational workflows
◆ Notable
- Raised €30 million Series A on 2026-09-22
- Round co-led by RAISE France and Orange Ventures
- Previously raised a €6 million seed round in November 2024
- Opened a Boston office for U.S. expansion
◆ Funding rounds
◆ Explore the market
◆ FAQ
What does Biolevate do?
Paris-based life sciences AI company providing an enterprise agentic AI platform for automating scientific and regulatory workflows in drug development.
Where is Biolevate based?
Biolevate is based in Paris, France, founded in 2024.
How much has Biolevate raised?
Biolevate has raised $34.4M in tracked funding and is currently at the series-a stage.
Who has invested in Biolevate?
Investors in Biolevate include RAISE France, Orange Ventures, MSD Global Health Innovation Fund, Station F and EQT Ventures.